$HSTO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Histogen Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Histogen Inc.. Get notifications about new insider transactions in Histogen Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2014 | CNAT | Conatus Pharmaceut ... | Scopa James Paul | Director | Option Exercise | A | 7.97 | 15,000 | 119,550 | 15,000 | |
| Jun 23 2014 | CNAT | Conatus Pharmaceut ... | Malik Shahzad | Director | Option Exercise | A | 7.97 | 15,000 | 119,550 | 15,000 | |
| Jun 23 2014 | CNAT | Conatus Pharmaceut ... | LACASSE LOUIS P | Director | Option Exercise | A | 7.97 | 15,000 | 119,550 | 15,000 | |
| Jun 23 2014 | CNAT | Conatus Pharmaceut ... | HALE DAVID F | Director | Option Exercise | A | 7.97 | 35,000 | 278,950 | 35,000 | |
| Feb 25 2014 | CNAT | Conatus Pharmaceut ... | KISNER DANIEL L | Director | Buy | J | 0.00 | 3,145 | 0 | 3,145 | 0 to 3.1 K |
| Feb 25 2014 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Buy | J | 0.00 | 8,731 | 0 | 8,731 | 0 to 8.7 K |
| Feb 25 2014 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Buy | J | 0.00 | 20,322 | 0 | 20,322 | 0 to 20.3 K |
| Feb 25 2014 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Sell | J | 0.00 | 36,634 | 0 | 0 | 36.6 K to 0 (-100.00 %) |
| Feb 25 2014 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Buy | J | 0.00 | 36,634 | 0 | 36,634 | 0 to 36.6 K |
| Feb 25 2014 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Sell | J | 0.00 | 30,216 | 0 | 22,203 | 52.4 K to 22.2 K (-57.64 %) |
| Feb 25 2014 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Sell | J | 0.00 | 1,283,589 | 0 | 943,355 | 2.2 M to 943.4 K (-57.64 %) |
| Feb 25 2014 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | Sell | J | 0.00 | 36,634 | 0 | 0 | 36.6 K to 0 (-100.00 %) | |
| Feb 25 2014 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | Buy | J | 0.00 | 36,634 | 0 | 36,634 | 0 to 36.6 K | |
| Feb 25 2014 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | Sell | J | 0.00 | 30,216 | 0 | 22,203 | 52.4 K to 22.2 K (-57.64 %) | |
| Feb 25 2014 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | Sell | J | 0.00 | 1,283,589 | 0 | 943,355 | 2.2 M to 943.4 K (-57.64 %) | |
| Feb 11 2014 | CNAT | Conatus Pharmaceut ... | Spada Alfred P. | SVP, R&D and CSO | Option Exercise | A | 9.45 | 50,000 | 472,500 | 50,000 | |
| Feb 11 2014 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | A | 9.45 | 400,000 | 3,780,000 | 400,000 | |
| Feb 11 2014 | CNAT | Conatus Pharmaceut ... | Cashion Charles | SVP, Finance, CFO a ... | Option Exercise | A | 9.45 | 50,000 | 472,500 | 50,000 | |
| Feb 11 2014 | CNAT | Conatus Pharmaceut ... | BURGESS GARY C. | Sr. VP, Clin. Res. ... | Option Exercise | A | 9.45 | 50,000 | 472,500 | 50,000 | |
| Feb 11 2014 | CNAT | Conatus Pharmaceut ... | Klassen Preston | Director | Option Exercise | A | 9.45 | 30,000 | 283,500 | 30,000 | |
| Feb 11 2014 | CNAT | Conatus Pharmaceut ... | KISNER DANIEL L | Director | Option Exercise | A | 9.45 | 30,000 | 283,500 | 30,000 | |
| Jan 10 2014 | CNAT | Conatus Pharmaceut ... | HALE DAVID F | Director | Option Exercise | M | 0.99 | 12,121 | 12,000 | 0 | |
| Jan 10 2014 | CNAT | Conatus Pharmaceut ... | HALE DAVID F | Director | Buy | M | 0.99 | 12,121 | 12,000 | 24,242 | 12.1 K to 24.2 K (+100.00 %) |
| Sep 27 2013 | CNAT | Conatus Pharmaceut ... | HALE DAVID F | Director | Option Exercise | M | 2.31 | 12,121 | 28,000 | 0 | |
| Sep 27 2013 | CNAT | Conatus Pharmaceut ... | HALE DAVID F | Director | Buy | M | 2.31 | 12,121 | 28,000 | 12,121 | 0 to 12.1 K |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Van Wart Harold | Director | Option Exercise | A | 11.00 | 30,000 | 330,000 | 30,000 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Spada Alfred P. | SVP, R&D and CSO | Option Exercise | C | 0.00 | 363,927 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Spada Alfred P. | SVP, R&D and CSO | Buy | C | 0.00 | 44,112 | 0 | 235,021 | 190.9 K to 235 K (+23.11 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Perret Marc Olivier | Director | Option Exercise | A | 11.00 | 30,000 | 330,000 | 30,000 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Perret Marc Olivier | Director | Option Exercise | X | 0.00 | 385,070 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Perret Marc Olivier | Director | Option Exercise | C | 0.00 | 3,717,861 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Perret Marc Olivier | Director | Option Exercise | C | 0.00 | 6,666,668 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Perret Marc Olivier | Director | Buy | P | 11.00 | 165,525 | 1,820,775 | 1,487,320 | 1.3 M to 1.5 M (+12.52 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Perret Marc Olivier | Director | Buy | J | 11.00 | 16,742 | 184,162 | 1,321,795 | 1.3 M to 1.3 M (+1.28 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Perret Marc Olivier | Director | Sell | S | 11.00 | 352 | 3,872 | 1,305,053 | 1.3 M to 1.3 M (-0.03 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Perret Marc Olivier | Director | Buy | X | 0.00 | 46,675 | 0 | 1,305,405 | 1.3 M to 1.3 M (+3.71 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Perret Marc Olivier | Director | Buy | C | 0.00 | 1,258,730 | 0 | 1,258,730 | 0 to 1.3 M |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | 10% Owner | Option Exercise | C | 7.43 | 120 | 892 | 120 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | 10% Owner | Option Exercise | C | 0.90 | 997 | 897 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | 10% Owner | Option Exercise | X | 0.08 | 1,727 | 142 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | 10% Owner | Option Exercise | C | 0.08 | 1,727 | 142 | 1,727 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | 10% Owner | Option Exercise | C | 0.01 | 5,701 | 57 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | 10% Owner | Option Exercise | C | 0.01 | 8,552 | 86 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | 10% Owner | Option Exercise | C | 0.00 | 137,626 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | 10% Owner | Option Exercise | C | 0.00 | 246,775 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | 10% Owner | Option Exercise | C | 7.43 | 5,131 | 38,123 | 5,131 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | 10% Owner | Option Exercise | C | 0.90 | 42,336 | 38,102 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | 10% Owner | Option Exercise | X | 0.08 | 73,395 | 6,055 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | 10% Owner | Option Exercise | C | 0.08 | 73,395 | 6,055 | 73,395 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | 10% Owner | Option Exercise | C | 0.01 | 242,205 | 2,422 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | 10% Owner | Option Exercise | C | 0.01 | 363,308 | 3,633 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | 10% Owner | Option Exercise | C | 0.00 | 5,846,236 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | 10% Owner | Option Exercise | C | 0.00 | 10,483,166 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | 10% Owner | Buy | P | 11.00 | 2,470 | 27,170 | 52,419 | 49.9 K to 52.4 K (+4.95 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | 10% Owner | Buy | J | 11.00 | 251 | 2,761 | 49,949 | 49.7 K to 49.9 K (+0.51 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | 10% Owner | Sell | S | 11.00 | 14 | 154 | 49,698 | 49.7 K to 49.7 K (-0.03 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | 10% Owner | Buy | X | 0.08 | 1,727 | 142 | 49,712 | 48 K to 49.7 K (+3.60 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | 10% Owner | Buy | C | 0.00 | 46,594 | 0 | 47,985 | 1.4 K to 48 K (+3,349.68 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | 10% Owner | Buy | P | 11.00 | 104,952 | 1,154,472 | 2,226,944 | 2.1 M to 2.2 M (+4.95 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | 10% Owner | Buy | J | 11.00 | 10,614 | 116,754 | 2,121,992 | 2.1 M to 2.1 M (+0.50 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | 10% Owner | Sell | S | 11.00 | 552 | 6,072 | 2,111,378 | 2.1 M to 2.1 M (-0.03 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | 10% Owner | Buy | X | 0.08 | 73,395 | 6,055 | 2,111,930 | 2 M to 2.1 M (+3.60 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Aberdare GP III, L.L.C. | 10% Owner | Buy | C | 0.00 | 1,979,321 | 0 | 2,038,535 | 59.2 K to 2 M (+3,342.66 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Option Exercise | C | 0.00 | 786,417 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Buy | P | 11.00 | 13,800 | 151,800 | 385,669 | 371.9 K to 385.7 K (+3.71 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Buy | J | 11.00 | 1,395 | 15,345 | 371,869 | 370.5 K to 371.9 K (+0.38 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Mento Steven J | President, CEO & Di ... | Buy | C | 0.00 | 95,323 | 0 | 370,474 | 275.2 K to 370.5 K (+34.64 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Option Exercise | A | 11.00 | 30,000 | 330,000 | 30,000 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Option Exercise | C | 7.43 | 120 | 892 | 120 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Option Exercise | C | 0.90 | 997 | 897 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Option Exercise | X | 0.08 | 1,727 | 142 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Option Exercise | C | 0.08 | 1,727 | 142 | 1,727 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Option Exercise | C | 0.01 | 5,701 | 57 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Option Exercise | C | 0.01 | 8,552 | 86 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Option Exercise | C | 0.00 | 137,626 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Option Exercise | C | 0.00 | 246,775 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Option Exercise | C | 7.43 | 5,131 | 38,123 | 5,131 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Option Exercise | C | 0.90 | 42,336 | 38,102 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Option Exercise | X | 0.08 | 73,395 | 6,055 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Option Exercise | C | 0.08 | 73,395 | 6,055 | 73,395 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Option Exercise | C | 0.01 | 242,205 | 2,422 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Option Exercise | C | 0.01 | 363,308 | 3,633 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Option Exercise | C | 0.00 | 5,846,236 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Option Exercise | C | 0.00 | 10,483,166 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Buy | P | 11.00 | 2,470 | 27,170 | 52,419 | 49.9 K to 52.4 K (+4.95 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Buy | J | 11.00 | 251 | 2,761 | 49,949 | 49.7 K to 49.9 K (+0.51 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Sell | S | 11.00 | 14 | 154 | 49,698 | 49.7 K to 49.7 K (-0.03 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Buy | X | 0.08 | 1,727 | 142 | 49,712 | 48 K to 49.7 K (+3.60 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Buy | C | 0.00 | 46,594 | 0 | 47,985 | 1.4 K to 48 K (+3,349.68 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Buy | P | 11.00 | 104,952 | 1,154,472 | 2,226,944 | 2.1 M to 2.2 M (+4.95 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Buy | J | 11.00 | 10,614 | 116,754 | 2,121,992 | 2.1 M to 2.1 M (+0.50 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Sell | S | 11.00 | 552 | 6,072 | 2,111,378 | 2.1 M to 2.1 M (-0.03 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Buy | X | 0.08 | 73,395 | 6,055 | 2,111,930 | 2 M to 2.1 M (+3.60 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | KLINGENSTEIN PAUL H | Director | Buy | C | 0.00 | 1,979,321 | 0 | 2,038,535 | 59.2 K to 2 M (+3,342.66 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Malik Shahzad | Director | Option Exercise | A | 11.00 | 30,000 | 330,000 | 30,000 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Malik Shahzad | Director | Option Exercise | X | 0.00 | 577,599 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Malik Shahzad | Director | Option Exercise | C | 0.00 | 5,576,786 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Malik Shahzad | Director | Option Exercise | C | 0.00 | 10,000,000 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Malik Shahzad | Director | Buy | P | 11.00 | 190,054 | 2,090,594 | 2,166,836 | 2 M to 2.2 M (+9.61 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Malik Shahzad | Director | Buy | J | 11.00 | 19,223 | 211,453 | 1,976,782 | 2 M to 2 M (+0.98 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Malik Shahzad | Director | Sell | S | 11.00 | 535 | 5,885 | 1,957,559 | 2 M to 2 M (-0.03 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Malik Shahzad | Director | Buy | X | 0.08 | 70,003 | 5,775 | 1,958,094 | 1.9 M to 2 M (+3.71 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Malik Shahzad | Director | Buy | C | 0.00 | 1,888,091 | 0 | 1,888,091 | 0 to 1.9 M |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | HALE DAVID F | Director | Option Exercise | A | 11.00 | 50,000 | 550,000 | 50,000 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | HALE DAVID F | Director | Option Exercise | C | 0.00 | 162,356 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | HALE DAVID F | Director | Buy | P | 11.00 | 2,588 | 28,468 | 143,739 | 141.2 K to 143.7 K (+1.83 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | HALE DAVID F | Director | Buy | J | 11.00 | 261 | 2,871 | 141,151 | 140.9 K to 141.2 K (+0.19 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | HALE DAVID F | Director | Buy | C | 0.00 | 19,679 | 0 | 140,890 | 121.2 K to 140.9 K (+16.24 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | LACASSE LOUIS P | Director | Option Exercise | A | 11.00 | 30,000 | 330,000 | 30,000 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | LACASSE LOUIS P | Director | Option Exercise | C | 0.00 | 5,555,556 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | LACASSE LOUIS P | Director | Buy | P | 11.00 | 123,950 | 1,363,450 | 809,887 | 685.9 K to 809.9 K (+18.07 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | LACASSE LOUIS P | Director | Buy | J | 11.00 | 12,537 | 137,907 | 685,937 | 673.4 K to 685.9 K (+1.86 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | LACASSE LOUIS P | Director | Buy | C | 0.00 | 673,400 | 0 | 673,400 | 0 to 673.4 K |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Cashion Charles | SVP, Finance, CFO a ... | Option Exercise | C | 0.00 | 355,352 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Cashion Charles | SVP, Finance, CFO a ... | Buy | C | 0.00 | 43,072 | 0 | 149,738 | 106.7 K to 149.7 K (+40.38 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | ADVENT VENTURE PARTNERS LLP | 10% Owner | Option Exercise | X | 0.00 | 577,599 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | ADVENT VENTURE PARTNERS LLP | 10% Owner | Option Exercise | C | 0.00 | 5,576,786 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | ADVENT VENTURE PARTNERS LLP | 10% Owner | Option Exercise | C | 0.00 | 10,000,000 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | ADVENT VENTURE PARTNERS LLP | 10% Owner | Buy | P | 11.00 | 190,054 | 2,090,594 | 2,166,836 | 2 M to 2.2 M (+9.61 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | ADVENT VENTURE PARTNERS LLP | 10% Owner | Buy | J | 11.00 | 19,223 | 211,453 | 1,976,782 | 2 M to 2 M (+0.98 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | ADVENT VENTURE PARTNERS LLP | 10% Owner | Sell | S | 11.00 | 535 | 5,885 | 1,957,559 | 2 M to 2 M (-0.03 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | ADVENT VENTURE PARTNERS LLP | 10% Owner | Buy | X | 0.08 | 70,003 | 5,775 | 1,958,094 | 1.9 M to 2 M (+3.71 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | ADVENT VENTURE PARTNERS LLP | 10% Owner | Buy | C | 0.00 | 1,888,091 | 0 | 1,888,091 | 0 to 1.9 M |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | COOPERATIVE GILDE HEALTHCARE I ... | 10% Owner | Option Exercise | X | 0.00 | 385,070 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | COOPERATIVE GILDE HEALTHCARE I ... | 10% Owner | Option Exercise | C | 0.00 | 3,717,861 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | COOPERATIVE GILDE HEALTHCARE I ... | 10% Owner | Option Exercise | C | 0.00 | 6,666,668 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | COOPERATIVE GILDE HEALTHCARE I ... | 10% Owner | Buy | P | 11.00 | 165,525 | 1,820,775 | 1,487,320 | 1.3 M to 1.5 M (+12.52 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | COOPERATIVE GILDE HEALTHCARE I ... | 10% Owner | Buy | J | 11.00 | 16,742 | 184,162 | 1,321,795 | 1.3 M to 1.3 M (+1.28 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | COOPERATIVE GILDE HEALTHCARE I ... | 10% Owner | Sell | S | 11.00 | 352 | 3,872 | 1,305,053 | 1.3 M to 1.3 M (-0.03 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | COOPERATIVE GILDE HEALTHCARE I ... | 10% Owner | Buy | X | 0.00 | 46,675 | 0 | 1,305,405 | 1.3 M to 1.3 M (+3.71 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | COOPERATIVE GILDE HEALTHCARE I ... | 10% Owner | Buy | C | 0.00 | 1,258,730 | 0 | 1,258,730 | 0 to 1.3 M |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | MPM BioVentures IV QP LP | 10% Owner | Option Exercise | C | 7.43 | 32,220 | 239,395 | 32,220 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | MPM BioVentures IV QP LP | 10% Owner | Option Exercise | C | 0.90 | 265,837 | 239,253 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | MPM BioVentures IV QP LP | 10% Owner | Option Exercise | C | 0.00 | 8,333,334 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | MPM BioVentures IV QP LP | 10% Owner | Buy | P | 11.00 | 165,265 | 1,817,915 | 1,192,080 | 1 M to 1.2 M (+16.09 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | MPM BioVentures IV QP LP | 10% Owner | Buy | J | 11.00 | 16,716 | 183,876 | 1,026,815 | 1 M to 1 M (+1.65 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | MPM BioVentures IV QP LP | 10% Owner | Buy | C | 0.00 | 1,010,099 | 0 | 1,010,099 | 0 to 1 M |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Scopa James Paul | Director | Option Exercise | A | 11.00 | 30,000 | 330,000 | 30,000 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Scopa James Paul | Director | Option Exercise | C | 7.43 | 32,220 | 239,395 | 32,220 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Scopa James Paul | Director | Option Exercise | C | 0.90 | 265,837 | 239,253 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Scopa James Paul | Director | Option Exercise | C | 0.00 | 8,333,334 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Scopa James Paul | Director | Buy | P | 11.00 | 165,265 | 1,817,915 | 1,192,080 | 1 M to 1.2 M (+16.09 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Scopa James Paul | Director | Buy | J | 11.00 | 16,716 | 183,876 | 1,026,815 | 1 M to 1 M (+1.65 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | Scopa James Paul | Director | Buy | C | 0.00 | 1,010,099 | 0 | 1,010,099 | 0 to 1 M |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | EVNIN LUKE | 10% Owner | Option Exercise | C | 7.43 | 32,220 | 239,395 | 32,220 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | EVNIN LUKE | 10% Owner | Option Exercise | C | 0.90 | 265,837 | 239,253 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | EVNIN LUKE | 10% Owner | Option Exercise | C | 0.00 | 8,333,334 | 0 | 0 | |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | EVNIN LUKE | 10% Owner | Buy | P | 11.00 | 165,265 | 1,817,915 | 1,192,080 | 1 M to 1.2 M (+16.09 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | EVNIN LUKE | 10% Owner | Buy | J | 11.00 | 16,716 | 183,876 | 1,026,815 | 1 M to 1 M (+1.65 %) |
| Aug 01 2013 | CNAT | Conatus Pharmaceut ... | EVNIN LUKE | 10% Owner | Buy | C | 0.00 | 1,010,099 | 0 | 1,010,099 | 0 to 1 M |